SC
BMY icon

Stolper & Co’s Bristol-Myers Squibb BMY Stock Holding History

Stolper & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,127
Closed -$1.34M – 88
2023
Q4 		$1.34M Sell
26,127
-565
-2% -$29.7K 0.54% 54
2023
Q3 		$1.55M Buy
26,692
+642
+2% +$39.3K 0.67% 48
2023
Q2 		$1.67M Buy
26,050
+160
+0.6% +$10.7K 0.7% 45
2023
Q1 		$1.79M Buy
25,890
+87
+0.3% +$6.14K 0.77% 41
2022
Q4 		$1.86M Sell
25,803
-4,425
-15% -$334K 0.81% 38
2022
Q3 		$2.15M Buy
30,228
+1,573
+5% +$114K 1.06% 34
2022
Q2 		$2.21M Buy
28,655
+593
+2% +$45.2K 1.03% 35
2022
Q1 		$2.05M Buy
28,062
+936
+3% +$62.8K 0.87% 40
2021
Q4 		$1.69M Buy
27,126
+474
+2% +$27.8K 0.75% 42
2021
Q3 		$1.58M Buy
26,652
+513
+2% +$33.8K 0.75% 43
2021
Q2 		$1.75M Buy
26,139
+216
+0.8% +$14.1K 0.82% 36
2021
Q1 		$1.64M Sell
25,923
-165
-0.6% -$10.3K 0.84% 37
2020
Q4 		$1.62M Buy
26,088
+485
+2% +$29.8K 0.91% 35
2020
Q3 		$1.54M Sell
25,603
-4,235
-14% -$255K 1% 31
2020
Q2 		$1.75M Sell
29,838
-2,015
-6% -$121K 1.15% 31
2020
Q1 		$1.77M Buy
+31,853
New +$1.95M 1.27% 28

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stolper & Co's BMY Position: Q1 2024 in Review

Stolper & Co sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 26,127 shares — an estimated $1.34M sold.

Stolper & Co first reported a position in BMY in Q1 2020 and held it in 16 quarters. The position peaked at $2.21M in Q2 2022. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Stolper & Co reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Stolper & Co sold 26,127 Bristol-Myers Squibb shares in Q1 2024, an estimated $1.34M.
  • Stolper & Co first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 16 quarters.
  • Stolper & Co's Bristol-Myers Squibb position peaked at $2.21M in Q2 2022.
  • 2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Stolper & Co's 13F filing for Q1 2024, filed 9 Apr 2024.